Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

16
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
16
Sample Proportion and Population Proportion01:20

Sample Proportion and Population Proportion

6.9K
Collecting samples or responses from an entire population takes significant time and effort, so a researcher collects responses from only a sample of that population. Suppose a study needs to collect information about a specific mobile application. After sample collection, the researcher analyzes the data and discovers that most individuals in the sample use that specific mobile application. The sample proportion measures the number of individuals in a sample who either use or don't use the...
6.9K
Confirmation Biases01:31

Confirmation Biases

8.3K
The confirmation bias is the tendency to focus on information that confirms our existing beliefs and ignore information that is inconsistent with our expectations. For example, if you think that your professor is not very nice, you notice all of the instances of rude behavior exhibited by the professor while ignoring the countless pleasant interactions he is involved in on a daily basis. Have you ever fallen prey to the confirmation bias, either as the source or target of such bias?
8.3K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

296
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
296
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

598
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
598
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

267
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
267

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T cell exhaustion and senescence for ovarian cancer immunotherapy.

Seminars in cancer biology·2024
Same author

Photon-beam-inducing synthesis of a tunable porous graphene/Ti<sub>3</sub>C<sub>2</sub>T<i><sub>x</sub></i>heterostructure for energy conversion-storage system.

Nanotechnology·2024
Same author

ICDW-YOLO: An Efficient Timber Construction Crack Detection Algorithm.

Sensors (Basel, Switzerland)·2024
Same author

Rational Molecular Design of a Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2D6.

Angewandte Chemie (International ed. in English)·2024
Same author

Differences in Clinical Outcomes between One-Stage and Staged Flexible Ureteroscopy for the Treatment of Upper Urinary Tract Stones.

Archivos espanoles de urologia·2024
Same author

Optimization of immunosuppression strategies for the establishment of chronic hepatitis E virus infection in rabbits.

Journal of virology·2024

Related Experiment Video

Updated: Feb 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K

Model diagnostics for the proportional hazards model with length-biased data.

Chi Hyun Lee1, Jing Ning2, Yu Shen2

  • 1Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street Unit 1411, Houston, TX, 77030, USA. clee9@mdanderson.org.

Lifetime Data Analysis
|February 17, 2018
PubMed
Summary

This study introduces a new statistical tool to validate proportional hazards models in length-biased data, crucial for accurate survival analysis in cohort studies. The methods ensure reliable inference for covariate effects in dementia research.

Keywords:
DementiaLength-biased dataModel diagnosticsProportional hazards modelStochastic processes

More Related Videos

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression
06:27

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression

Published on: July 11, 2025

1.0K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

Related Experiment Videos

Last Updated: Feb 14, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.9K
An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression
06:27

An Olfactory Preference Test for Measuring Olfactory Hedonic Biases in Mouse Models of Depression

Published on: July 11, 2025

1.0K
Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.4K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Survival Analysis

Background:

  • Length-biased data are common in cohort studies, complicating survival outcome analysis.
  • Existing statistical methods often adjust for length-biased sampling but lack assumption checking.
  • Proportional hazards models are widely used but their validity with length-biased data is under-examined.

Purpose of the Study:

  • To develop and validate a statistical tool for checking proportional hazards model assumptions with length-biased data.
  • To provide graphical and analytical methods for assessing covariate functional form and hazard proportionality.
  • To ensure the validity of statistical inference in survival analysis involving length-biased sampling.

Main Methods:

  • Proposed a general class of multiparameter stochastic processes for analysis.
  • Developed graphical and analytical tools for assumption checking.
  • Employed simulation studies to evaluate finite sample performance.

Main Results:

  • The proposed statistical tool effectively tests proportional hazards model assumptions in length-biased data.
  • Simulation studies demonstrate good performance of the developed methods.
  • The methods were successfully applied to a Canadian dementia cohort study.

Conclusions:

  • The developed statistical tool enhances the reliability of survival analysis with length-biased data.
  • Graphical and analytical checks are essential for valid inference in proportional hazards models.
  • This work provides a robust framework for analyzing complex cohort data, exemplified by dementia research.